Publications

Publications published since 2008 from OUS - Oslo Center for Clinical Heart Research

392 publications found

Publications 2024

1. Raju SC, Molinaro A, Awoyemi A, Jørgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegård KT, Halvorsen B, Kristiansen K, Hov JR, Trøseid M (2024)
   Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
   Genome Med, 16 (1), 27
   DOI 10.1186/s13073-024-01296-6, PubMed 38331891
2. Rypdal KB, Apte SS, Lunde IG (2024)
   Emerging roles for the ADAMTS-like family of matricellular proteins in cardiovascular disease through regulation of the extracellular microenvironment
   Mol Biol Rep, 51 (1), 280
   DOI 10.1007/s11033-024-09255-5, PubMed 38324186

Publications 2023

1. Alehagen U, Alexander J, Aaseth JO, Larsson A, Svensson E, Opstad TB (2023)
   Effects of an Intervention with Selenium and Coenzyme Q₁₀ on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial
   Cells, 12 (13)
   DOI 10.3390/cells12131773, PubMed 37443807
2. Eastwood G, Nichol AD, Hodgson C, Parke RL, McGuinness S, Nielsen N, Bernard S, Skrifvars MB, Stub D, Taccone FS, Archer J, Kutsogiannis D, Dankiewicz J, Lilja G, Cronberg T, Kirkegaard H, Capellier G, Landoni G, Horn J, Olasveengen T, Arabi Y, Chia YW, Markota A, Hænggi M, Wise MP et al. (2023)
   Mild Hypercapnia or Normocapnia after Out-of-Hospital Cardiac Arrest
   N Engl J Med, 389 (1), 45-57
   DOI 10.1056/NEJMoa2214552, PubMed 37318140
3. Gragnano F, Cao D, Pirondini L, Franzone A, Kim HS, von Scheidt M, Pettersen AR, Zhao Q, Woodward M, Chiarito M, McFadden EP, Park KW, Kastrati A, Seljeflot I, Zhu Y, Windecker S, Kang J, Schunkert H, Arnesen H, Bhatt DL, Steg PG, Calabrò P, Pocock S, Mehran R, Valgimigli M et al. (2023)
   P2Y₁₂ Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
   J Am Coll Cardiol, 82 (2), 89-105
   DOI 10.1016/j.jacc.2023.04.051, PubMed 37407118
4. Myhre PL, Berge T, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Solheim S, Arnesen H, Seljeflot I, Tveit A (2023)
   Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial
   Clin Nutr, 42 (9), 1657-1660
   DOI 10.1016/j.clnu.2023.07.002, PubMed 37515843
5. Nendl A, Raju SC, Broch K, Mayerhofer CCK, Holm K, Halvorsen B, Lappegård KT, Moscavitch S, Hov JR, Seljeflot I, Trøseid M, Awoyemi A (2023)
   Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
   Front Cardiovasc Med, 10, 1160030
   DOI 10.3389/fcvm.2023.1160030, PubMed 37332580
6. Nilsen DWT, Myhre PL, Solheim S, Tveit SH, Kalstad AA, Laake K, Tveit A, Seljeflot I (2023)
   Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly
   Antioxidants (Basel), 12 (6)
   DOI 10.3390/antiox12061157, PubMed 37371887
7. Opstad TB, Alexander J, Aaseth J, Larsson A, Seljeflot I, Alehagen U (2023)
   Increased SIRT1 Concentration Following Four Years of Selenium and Q₁₀ Intervention Associated with Reduced Cardiovascular Mortality at 10-Year Follow-Up-Sub-Study of a Previous Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial
   Antioxidants (Basel), 12 (3)
   DOI 10.3390/antiox12030759, PubMed 36979007
8. Opstad TB, Papotti B, Åkra S, Hansen CH, Braathen B, Tønnessen T, Solheim S, Seljeflot I (2023)
   Sirtuin1, not NAMPT, possesses anti-inflammatory effects in epicardial, pericardial and subcutaneous adipose tissue in patients with CHD
   J Transl Med, 21 (1), 644
   DOI 10.1186/s12967-023-04518-4, PubMed 37730614
9. Papotti B, Opstad TB, Åkra S, Tønnessen T, Braathen B, Hansen CH, Arnesen H, Solheim S, Seljeflot I, Ronda N (2023)
   Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease
   Front Cardiovasc Med, 10, 1055069
   DOI 10.3389/fcvm.2023.1055069, PubMed 36937936
10. Sasi A, Romaine A, Erusappan PM, Melleby AO, Hasic A, Dahl CP, Broch K, Almaas VM, Puertas RD, Roderick HL, Lunde IG, Sjaastad I, Vistnes M, Christensen G (2023)
    Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development
    Matrix Biol Plus, 19-20, 100135
    DOI 10.1016/j.mbplus.2023.100135, PubMed 38076279
11. Simeunovic A, Brunborg C, Heier M, Seljeflot I, Dahl-Jørgensen K, Margeirsdottir HD (2023)
    Sustained low-grade inflammation in young participants with childhood onset type 1 diabetes: The Norwegian atherosclerosis and childhood diabetes (ACD) study
    Atherosclerosis, 379, 117151
    DOI 10.1016/j.atherosclerosis.2023.05.020, PubMed 37349194
12. Warlo EMK, Kalstad AA, Myhre PL, Solheim S, Arnesen H, Tveit A, Holme PA, Seljeflot I, Bratseth V (2023)
    von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
    Res Pract Thromb Haemost, 7 (4), 100164
    DOI 10.1016/j.rpth.2023.100164, PubMed 37255854
13. Woxholt S, Ueland T, Aukrust P, Anstensrud AK, Broch K, Tøllefsen IM, Ryan L, Bendz B, Hopp E, Kløw NE, Seljeflot I, Halvorsen B, Dahl TB, Huse C, Andersen GØ, Gullestad L, Wiseth R, Amundsen BH, Damas JK, Kleveland O (2023)
    Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
    Open Heart, 10 (2)
    DOI 10.1136/openhrt-2023-002301, PubMed 37591633
14. Aaseth JO, Alehagen U, Opstad TB, Alexander J (2023)
    Vitamin K and Calcium Chelation in Vascular Health
    Biomedicines, 11 (12)
    DOI 10.3390/biomedicines11123154, PubMed 38137375

Publications 2022

1. Aukrust SG, Holte KB, Opstad TB, Seljeflot I, Berg TJ, Helseth R (2022)
   NETosis in Long-Term Type 1 Diabetes Mellitus and Its Link to Coronary Artery Disease
   Front Immunol, 12, 799539
   DOI 10.3389/fimmu.2021.799539, PubMed 35069582
2. Aune SK, Bonnevie-Svendsen M, Nyborg C, Trøseid M, Seljeflot I, Hisdal J, Helseth R (2022)
   Gut Leakage and Cardiac Biomarkers after Prolonged Strenuous Exercise
   Med Sci Sports Exerc, 54 (9), 1476-1482
   DOI 10.1249/MSS.0000000000002948, PubMed 35482788
3. Awoyemi A, Hov JR, Trøseid M (2022)
   Phenylacetylglutamine From the Gut Microbiota: A Future Therapeutic Target in Heart Failure?
   Circ Heart Fail, 16 (1), e010222
   DOI 10.1161/CIRCHEARTFAILURE.122.010222, PubMed 36524473
4. Berge T, Myhre PL, Kalstad AA, Laake K, Tveit SH, Onarheim S, Solheim S, Seljeflot I, Arnesen H, Tveit A (2022)
   Screen-Detected Atrial Fibrillation and "Micro-Atrial Fibrillation" and Risk of Cardiovascular Events after Myocardial Infarction in Elderly Patients
   Cardiology, 148 (1), 72-77
   DOI 10.1159/000528726, PubMed 36538900
5. Bratseth V, Nordeng J, Helseth R, Solheim S, Åkra S, Arnesen H, Chiva-Blanch G, Seljeflot I (2022)
   Circulating Microvesicles in Association with the NLRP3 Inflammasome in Coronary Thrombi from STEMI Patients
   Biomedicines, 10 (9)
   DOI 10.3390/biomedicines10092196, PubMed 36140297
6. Cwikiel J, Fagerland MW, Wachtell K, Arnesen H, Seljeflot I, Flaa A (2022)
   Exercise-induced change in circulating NT-proBNP could not distinguish between patients with and without coronary artery disease: the CADENCE study
   Scand Cardiovasc J, 56 (1), 107-113
   DOI 10.1080/14017431.2022.2075562, PubMed 35593516
7. Hansen CH, Cwikiel J, Bratseth V, Arnesen H, Flaa A, Seljeflot I (2022)
   Effect of Revascularization on Exercise-Induced Changes in Cardiac and Prothrombotic Biomarkers in Patients with Coronary Artery Disease
   Clin Appl Thromb Hemost, 28, 10760296221094029
   DOI 10.1177/10760296221094029, PubMed 35437054
8. Huse C, Anstensrud AK, Michelsen AE, Ueland T, Broch K, Woxholt S, Yang K, Sharma K, Tøllefsen IM, Bendz B, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Quiles-Jiménez A, Bjerkeli V, Bendz C, Kleveland O, Stensaeth KH, Opdahl A, Kløw NE, Andersen GØ, Wiseth R, Halvorsen B, Gullestad L et al. (2022)
   Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
   EBioMedicine, 80, 104013
   DOI 10.1016/j.ebiom.2022.104013, PubMed 35504178
9. Kluge KE, Langseth MS, Andersen GØ, Halvorsen S, Opstad TB, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2022)
   Complement activation in association with clinical outcomes in ST-elevation myocardial infarction
   Am Heart J Plus, 24, 100228
   DOI 10.1016/j.ahjo.2022.100228, PubMed 38560636
10. Kluge KE, Seljeflot I, Arnesen H, Jensen T, Halvorsen S, Helseth R (2022)
    Coagulation factors XI and XII as possible targets for anticoagulant therapy
    Thromb Res, 214, 53-62
    DOI 10.1016/j.thromres.2022.04.013, PubMed 35490644
11. Kyte KH, Stensrud T, Berg TJ, Seljeflot I, Hisdal J (2022)
    Vascular Function in Norwegian Female Elite Runners: A Cross-Sectional, Controlled Study
    Sports (Basel), 10 (3)
    DOI 10.3390/sports10030037, PubMed 35324646
12. Meyer-Myklestad MH, Medhus AW, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Stiksrud B, Trøseid M, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Reikvam DH (2022)
    Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
    J Infect Dis, 225 (4), 661-674
    DOI 10.1093/infdis/jiaa714, PubMed 33216130
13. Meyer-Myklestad MH, Medhus AW, Stiksrud B, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Trøseid M, Reikvam DH (2022)
    Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum
    J Acquir Immune Defic Syndr, 89 (1), 77-86
    DOI 10.1097/QAI.0000000000002817, PubMed 34878437
14. Molvaer AK, Iversen MM, Igland J, Peyrot M, Tell GS, Holte KB, Monnier VM, Seljeflot I, Berg TJ (2022)
    Metabolic predictors of pain, fatigue, depression and quality of life in people with long-term type 1 diabetes-the Dialong study
    Diabet Med, 40 (3), e15009
    DOI 10.1111/dme.15009, PubMed 36398424
15. Myhre PL, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Solheim S, Arnesen H, Seljeflot I (2022)
    Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial
    J Intern Med, 291 (5), 637-647
    DOI 10.1111/joim.13442, PubMed 34982486
16. Nordeng J, Schandiz H, Solheim S, Åkra S, Hoffman P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2022)
    TIMP-1 expression in coronary thrombi associate with myocardial injury in ST-elevation myocardial infarction patients
    Coron Artery Dis, 33 (6), 446-455
    DOI 10.1097/MCA.0000000000001128, PubMed 35102064
17. Nordeng J, Solheim S, Åkra S, Schandiz H, Hoffmann P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2022)
    Gene expression of fibrinolytic markers in coronary thrombi
    Thromb J, 20 (1), 23
    DOI 10.1186/s12959-022-00383-1, PubMed 35488283
18. Opstad TB, Alexander J, Aaseth JO, Larsson A, Seljeflot I, Alehagen U (2022)
    Selenium and Coenzyme Q₁₀ Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial
    Nutrients, 14 (16)
    DOI 10.3390/nu14163346, PubMed 36014852
19. Opstad TB, Farup PG, Rootwelt H, Aaseth JO (2022)
    Changes in circulating sirtuin 1 after bariatric surgery
    Nutr Metab Cardiovasc Dis, 32 (12), 2858-2864
    DOI 10.1016/j.numecd.2022.09.009, PubMed 36404480
20. Opstad TB, Nordeng J, Pettersen AR, Åkra S, Bratseth V, Zaidi H, Helseth R, Solheim S, Seljeflot I (2022)
    The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome
    J Immunol Res, 2022, 2366695
    DOI 10.1155/2022/2366695, PubMed 36582742
21. Opstad TB, Solheim S, Pettersen AR, Kalstad AA, Arnesen H, Seljeflot I (2022)
    TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients-A Possible Link to Clonal Hematopoiesis
    Biomedicines, 10 (8)
    DOI 10.3390/biomedicines10082027, PubMed 36009574
22. Romaine A, Melleby AO, Alam J, Lobert VH, Lu N, Lockwood FE, Hasic A, Lunde IG, Sjaastad I, Stenmark H, Herum KM, Gullberg D, Christensen G (2022)
    Integrin α11β1 and syndecan-4 dual receptor ablation attenuate cardiac hypertrophy in the pressure overloaded heart
    Am J Physiol Heart Circ Physiol, 322 (6), H1057-H1071
    DOI 10.1152/ajpheart.00635.2021, PubMed 35522553
23. Warlo EMK, Bratseth V, Pettersen AR, Holme PA, Arnesen H, Seljeflot I, Opstad TB (2022)
    Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
    Clin Appl Thromb Hemost, 28, 10760296221141893
    DOI 10.1177/10760296221141893, PubMed 36474435
24. Zaidi H, Aksnes T, Åkra S, Eggesbø HB, Byrkjeland R, Seljeflot I, Opstad TB (2022)
    Abdominal Adipose Tissue Associates With Adiponectin and TNFα in Middle-Aged Healthy Men
    Front Endocrinol (Lausanne), 13, 874977
    DOI 10.3389/fendo.2022.874977, PubMed 35872989
25. Åkra S, Seljeflot I, Braathen B, Bratseth V, Hansen CH, Arnesen H, Tønnessen T, Solheim S (2022)
    The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
    Atheroscler Plus, 48, 47-54
    DOI 10.1016/j.athplu.2022.03.005, PubMed 36644557

Publications 2021

1. Alehagen U, Opstad TB, Alexander J, Larsson A, Aaseth J (2021)
   Impact of Selenium on Biomarkers and Clinical Aspects Related to Ageing. A Review
   Biomolecules, 11 (10)
   DOI 10.3390/biom11101478, PubMed 34680111
2. Aune SK, Byrkjeland R, Solheim S, Arnesen H, Trøseid M, Awoyemi A, Seljeflot I, Helseth R (2021)
   Gut related inflammation and cardiorespiratory fitness in patients with CAD and type 2 diabetes: a sub-study of a randomized controlled trial on exercise training
   Diabetol Metab Syndr, 13 (1), 36
   DOI 10.1186/s13098-021-00655-2, PubMed 33794977
3. Aune SK, Cwikiel J, Flaa A, Arnesen H, Solheim S, Awoyemi A, Trøseid M, Seljeflot I, Helseth R (2021)
   Gut Leakage Markers in Response to Strenuous Exercise in Patients with Suspected Coronary Artery Disease
   Cells, 10 (9)
   DOI 10.3390/cells10092193, PubMed 34571843
4. Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K (2021)
   Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
   EBioMedicine, 70, 103511
   DOI 10.1016/j.ebiom.2021.103511, PubMed 34329947
5. Broch K, Anstensrud AK, Woxholt S, Sharma K, Tøllefsen IM, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Bendz C, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L (2021)
   Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
   J Am Coll Cardiol, 77 (15), 1845-1855
   DOI 10.1016/j.jacc.2021.02.049, PubMed 33858620
6. Chaban V, Nakstad ER, Stær-Jensen H, Schjalm C, Seljeflot I, Vaage J, Lundqvist C, Benth JŠ, Sunde K, Mollnes TE, Andersen GØ, Pischke SE (2021)
   Complement activation is associated with poor outcome after out-of-hospital cardiac arrest
   Resuscitation, 166, 129-136
   DOI 10.1016/j.resuscitation.2021.05.038, PubMed 34126135
7. Chiva-Blanch G, Bratseth V, Laake K, Arnesen H, Solheim S, Schmidt EB, Badimon L, Seljeflot I (2021)
   One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction
   Clin Nutr, 40 (12), 5674-5677
   DOI 10.1016/j.clnu.2021.10.007, PubMed 34742136
8. Helseth R, Kleveland O, Ueland T, Wiseth R, Damas JK, Broch K, Michelsen A, Bendz B, Gullestad L, Aukrust P, Seljeflot I (2021)
   Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
   Open Heart, 8 (1)
   DOI 10.1136/openhrt-2020-001492, PubMed 33972404
9. Hoel H, Pettersen EM, Høiseth LØ, Mathiesen I, Seternes A, Seljeflot I, Hisdal J (2021)
   Effects of intermittent negative pressure treatment on circulating vascular biomarkers in patients with intermittent claudication
   Vasc Med, 26 (5), 489-496
   DOI 10.1177/1358863X211007933, PubMed 33985385
10. Holm S, Kared H, Michelsen AE, Kong XY, Dahl TB, Schultz NH, Nyman TA, Fladeby C, Seljeflot I, Ueland T, Stensland M, Mjaaland S, Goll GL, Nissen-Meyer LS, Aukrust P, Skagen K, Gregersen I, Skjelland M, Holme PA, Munthe LA, Halvorsen B (2021)
    Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
    Eur Heart J, 42 (39), 4064-4072
    DOI 10.1093/eurheartj/ehab506, PubMed 34405870
11. Kalstad AA, Myhre PL, Laake K, Opstad TB, Tveit A, Solheim S, Arnesen H, Seljeflot I (2021)
    Biomarkers of ageing and cardiac remodeling are associated with atrial fibrillation
    Scand Cardiovasc J, 55 (4), 213-219
    DOI 10.1080/14017431.2021.1889653, PubMed 33650449
12. Myhre P, Seljeflot I, Arnesen H (2021)
    [Myhre, Seljeflot and Arnesen respond]
    Tidsskr Nor Laegeforen, 141 (10)
    DOI 10.4045/tidsskr.21.0470, PubMed 34182730
13. Myhre PL, Seljeflot I, Arnesen H (2021)
    Omega-3 supplements do not prevent cardiovascular disease
    Tidsskr Nor Laegeforen, 141 (6)
    DOI 10.4045/tidsskr.21.0033, PubMed 33876607
14. Nilsen DWT, Myhre PL, Kalstad A, Schmidt EB, Arnesen H, Seljeflot I (2021)
    Serum Levels of Dihomo-Gamma (γ)-Linolenic Acid (DGLA) Are Inversely Associated with Linoleic Acid and Total Death in Elderly Patients with a Recent Myocardial Infarction
    Nutrients, 13 (10)
    DOI 10.3390/nu13103475, PubMed 34684479
15. Nordeng J, Schandiz H, Solheim S, Åkra S, Hoffman P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2021)
    The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI
    Mediators Inflamm, 2021, 5525917
    DOI 10.1155/2021/5525917, PubMed 34135690
16. Nyborg C, Bonnevie-Svendsen M, Melsom HS, Melau J, Seljeflot I, Hisdal J (2021)
    Reduced L-Arginine and L-Arginine-ADMA-Ratio, and Increased SDMA after Norseman Xtreme Triathlon
    Sports (Basel), 9 (9)
    DOI 10.3390/sports9090120, PubMed 34564325
17. Nyborg C, Melsom HS, Bonnevie-Svendsen M, Melau J, Seljeflot I, Hisdal J (2021)
    Transient Reduction of FMD-Response and L-Arginine Accompanied by Increased Levels of E-Selectin, VCAM, and ICAM after Prolonged Strenuous Exercise
    Sports (Basel), 9 (6)
    DOI 10.3390/sports9060086, PubMed 34204566
18. Omland T, Prebensen C, Jonassen C, Svensson M, Berdal JE, Seljeflot I, Myhre PL (2021)
    Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19
    Open Heart, 8 (2)
    DOI 10.1136/openhrt-2021-001884, PubMed 34933965
19. Opstad TB, Sundfør T, Tonstad S, Seljeflot I (2021)
    Effect of intermittent and continuous caloric restriction on Sirtuin1 concentration depends on sex and body mass index
    Nutr Metab Cardiovasc Dis, 31 (6), 1871-1878
    DOI 10.1016/j.numecd.2021.03.005, PubMed 33975734
20. Rønning P, Helseth E, Skaansar O, Tverdal C, Andelic N, Bhatnagar R, Melberg M, Skaga NO, Aarhus M, Halvorsen S, Helseth R (2021)
    Impact of Preinjury Antithrombotic Therapy on 30-Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)
    Front Neurol, 12, 650695
    DOI 10.3389/fneur.2021.650695, PubMed 34054695
21. Saeed M, Tapia G, Ariansen I, Stene LC, Seljeflot I, Tell GS, Skrivarhaug T, Joner G (2021)
    Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study
    Diabetes Care, 44 (3), 810-816
    DOI 10.2337/dc20-1712, PubMed 33408220
22. Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO (2021)
    Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial
    Sci Rep, 11 (1), 11593
    DOI 10.1038/s41598-021-90976-z, PubMed 34078971
23. Thomas AM, Chaban V, Pischke SE, Orrem HL, Bosnes V, Sunde K, Seljeflot I, Lundqvist C, Nakstad ER, Andersen GØ, Schjalm C, Mollnes TE, Barratt-Due A (2021)
    Complement ratios C3bc/C3 and sC5b-9/C5 do not increase the sensitivity of detecting acute complement activation systemically
    Mol Immunol, 141, 273-279
    DOI 10.1016/j.molimm.2021.11.016, PubMed 34906905
24. Tøllefsen IM, Shetelig C, Seljeflot I, Eritsland J, Hoffmann P, Andersen GØ (2021)
    High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
    Open Heart, 8 (2)
    DOI 10.1136/openhrt-2021-001869, PubMed 34933964
25. Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2021)
    Adiponectin in relation to exercise and physical performance in patients with type 2 diabetes and coronary artery disease
    Adipocyte, 10 (1), 612-620
    DOI 10.1080/21623945.2021.1996699, PubMed 34779349

Publications 2020

1. Arnesen H, Myhre PL, Seljeflot I (2020)
   Very Long Chain Marine n-3 Polyunsaturated Fatty Acids in Atherothrombotic Heart Disease. A Brief Review, with a Focus on Metabolic Effects
   Nutrients, 12 (10)
   DOI 10.3390/nu12103014, PubMed 33008057
2. Bratseth V, Margeirsdottir HD, Chiva-Blanch G, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
   Annexin V⁺ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study
   J Diabetes Res, 2020, 7216863
   DOI 10.1155/2020/7216863, PubMed 32309448
3. Bratseth V, Margeirsdottir HD, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
   Procoagulant activity in children and adolescents on intensive insulin therapy
   Pediatr Diabetes, 21 (3), 496-504
   DOI 10.1111/pedi.12978, PubMed 31943582
4. Danielsen SO, Moons P, Leegaard M, Solheim S, Tønnessen T, Lie I (2020)
   Facilitators of and barriers to reducing thirty-day readmissions and improving patient-reported outcomes after surgical aortic valve replacement: a process evaluation of the AVRre trial
   BMC Health Serv Res, 20 (1), 256
   DOI 10.1186/s12913-020-05125-5, PubMed 32220252
5. Herum KM, Romaine A, Wang A, Melleby AO, Strand ME, Pacheco J, Braathen B, Dunér P, Tønnessen T, Lunde IG, Sjaastad I, Brakebusch C, McCulloch AD, Gomez MF, Carlson CR, Christensen G (2020)
   Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin
   J Am Heart Assoc, 9 (3), e013518
   DOI 10.1161/JAHA.119.013518, PubMed 32000579
6. Hilde JM, Hisdal J, Skjørten I, Hansteen V, Melsom MN, Grøtta OJ, Småstuen MC, Seljeflot I, Arnesen H, Humerfelt S, Steine K (2020)
   Left ventricular dysfunction in COPD without pulmonary hypertension
   PLoS One, 15 (7), e0235075
   DOI 10.1371/journal.pone.0235075, PubMed 32673327
7. Holte KB, Svanteson M, Hanssen KF, Sveen KA, Seljeflot I, Solheim S, Sell DR, Monnier VM, Berg TJ (2020)
   Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
   PLoS One, 15 (5), e0233174
   DOI 10.1371/journal.pone.0233174, PubMed 32401813
8. Kalstad AA, Myhre PL, Laake K, Tveit SH, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Fagerland MW, Solheim S, Seljeflot I, Arnesen H, OMEMI Investigators (2020)
   Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial
   Circulation, 143 (6), 528-539
   DOI 10.1161/CIRCULATIONAHA.120.052209, PubMed 33191772
9. Kluge KE, Langseth MS, Bratseth V, Pettersen AÅ, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2020)
   Circulating levels of the terminal complement complex are associated with hypercoagulability in patients with stable coronary artery disease
   Thromb Res, 196, 106-108
   DOI 10.1016/j.thromres.2020.08.023, PubMed 32853976
10. Kluge KE, Langseth MS, Opstad TB, Pettersen AÅ, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2020)
    Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease
    Mediators Inflamm, 2020, 5080743
    DOI 10.1155/2020/5080743, PubMed 32308555
11. Kummen M, Solberg OG, Storm-Larsen C, Holm K, Ragnarsson A, Trøseid M, Vestad B, Skårdal R, Yndestad A, Ueland T, Svardal A, Berge RK, Seljeflot I, Gullestad L, Karlsen TH, Aaberge L, Aukrust P, Hov JR (2020)
    Rosuvastatin alters the genetic composition of the human gut microbiome
    Sci Rep, 10 (1), 5397
    DOI 10.1038/s41598-020-62261-y, PubMed 32214138
12. Langseth MS, Andersen GØ, Husebye T, Arnesen H, Zucknick M, Solheim S, Eritsland J, Seljeflot I, Opstad TB, Helseth R (2020)
    Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure
    PLoS One, 15 (10), e0241333
    DOI 10.1371/journal.pone.0241333, PubMed 33119664
13. Langseth MS, Helseth R, Ritschel V, Hansen CH, Andersen GØ, Eritsland J, Halvorsen S, Fagerland MW, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2020)
    Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
    Sci Rep, 10 (1), 5007
    DOI 10.1038/s41598-020-61971-7, PubMed 32193509
14. Mayerhofer CCK, Kummen M, Holm K, Broch K, Awoyemi A, Vestad B, Storm-Larsen C, Seljeflot I, Ueland T, Bohov P, Berge RK, Svardal A, Gullestad L, Yndestad A, Aukrust P, Hov JR, Trøseid M (2020)
    Low fibre intake is associated with gut microbiota alterations in chronic heart failure
    ESC Heart Fail, 7 (2), 456-466
    DOI 10.1002/ehf2.12596, PubMed 31978943
15. Mirza Y, Prestgaard EE, Selmer R, Liestøl K, Grundvold I, Erikssen JE, Kjeldsen SE, Gjesdal K (2020)
    [Ten-year prediction of cardiovascular disease in healthy Norwegian men, based on NORRISK-2]
    Tidsskr Nor Laegeforen, 140 (12)
    DOI 10.4045/tidsskr.20.0089, PubMed 32900157
16. Nakstad ER, Stær-Jensen H, Wimmer H, Henriksen J, Alteheld LH, Reichenbach A, Drægni T, Šaltytė-Benth J, Wilson JA, Etholm L, Øijordsbakken M, Eritsland J, Seljeflot I, Jacobsen D, Andersen GØ, Lundqvist C, Sunde K (2020)
    Late awakening, prognostic factors and long-term outcome in out-of-hospital cardiac arrest - results of the prospective Norwegian Cardio-Respiratory Arrest Study (NORCAST)
    Resuscitation, 149, 170-179
    DOI 10.1016/j.resuscitation.2019.12.031, PubMed 31926258
17. Niyonzima N, Bakke SS, Gregersen I, Holm S, Sandanger Ø, Orrem HL, Sporsheim B, Ryan L, Kong XY, Dahl TB, Skjelland M, Sørensen KK, Rokstad AM, Yndestad A, Latz E, Gullestad L, Andersen GØ, Damås JK, Aukrust P, Mollnes TE, Halvorsen B, Espevik T (2020)
    Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
    EBioMedicine, 60, 102985
    DOI 10.1016/j.ebiom.2020.102985, PubMed 32927275
18. Opstad TB, Berg TJ, Holte KB, Arnesen H, Solheim S, Seljeflot I (2020)
    Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long-term survivors of type 1 diabetes: A Dialong substudy
    J Diabetes Investig, 12 (7), 1183-1192
    DOI 10.1111/jdi.13470, PubMed 33249778
19. Opstad TB, Kalstad AA, Holte KB, Berg TJ, Solheim S, Arnesen H, Seljeflot I (2020)
    Shorter Leukocyte Telomere Lengths in Healthy Relatives of Patients with Coronary Heart Disease
    Rejuvenation Res, 23 (4), 324-332
    DOI 10.1089/rej.2019.2258, PubMed 31805818
20. Piuhola J, Kerkelä R, Laine M, Andersen GØ, Ērglis A, Kumsārs I, Thuesen L, Sinisalo J, Niemelä M, Junttila MJ (2020)
    Lower ST-elevation myocardial infarction incidence during COVID-19 epidemic in Northern Europe
    Scand Cardiovasc J, 54 (6), 358-360
    DOI 10.1080/14017431.2020.1820563, PubMed 32945201
21. Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Kjeldsen S, Grundvold I, Berge E (2020)
    Change in Body Weight and Long-Term Risk of Stroke and Death in Healthy Men
    Stroke, 51 (5), 1435-1441
    DOI 10.1161/STROKEAHA.119.027233, PubMed 32268850
22. Sandven I, Eritsland J, Abdelnoor M (2020)
    Remote Ischemic Conditioning in Patients with Acute Coronary Syndromes: A Systematic Review with Meta-Analysis and Trial Sequential Analysis
    Clin Epidemiol, 12, 595-605
    DOI 10.2147/CLEP.S249785, PubMed 32606985
23. Tollisen KH, Hadley CL, Bjerva M, Dahl GT, Högvall LM, Sandvik L, Andersen GØ, Heyerdahl F, Jacobsen D (2020)
    Clinical impact of chronic substance abuse in a Norwegian ICU-population
    Acta Anaesthesiol Scand, 65 (4), 515-524
    DOI 10.1111/aas.13766, PubMed 33340102
24. Trøseid M, Andersen GØ, Broch K, Hov JR (2020)
    The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
    EBioMedicine, 52, 102649
    DOI 10.1016/j.ebiom.2020.102649, PubMed 32062353
25. Tveit SH, Cwikiel J, Myhre PL, Omland T, Berge E, Seljeflot I, Flaa A (2020)
    Differential associations of cardiac troponin T and cardiac troponin I with coronary artery pathology and dynamics in response to short-duration exercise
    Clin Biochem, 88, 23-29
    DOI 10.1016/j.clinbiochem.2020.11.005, PubMed 33245871
26. Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I (2020)
    Markers of remodeling in subcutaneous adipose tissue are strongly associated with overweight and insulin sensitivity in healthy non-obese men
    Sci Rep, 10 (1), 14055
    DOI 10.1038/s41598-020-71109-4, PubMed 32820223

Publications 2019

1. Abdelnoor M, Sandven I, Vengen Ø, Risnes I (2019)
   Mediastinitis in open heart surgery: a systematic review and meta-analysis of risk factors
   Scand Cardiovasc J, 53 (5), 226-234
   DOI 10.1080/14017431.2019.1642508, PubMed 31290699
2. Anstensrud AK, Woxholt S, Sharma K, Broch K, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L (2019)
   Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
   Open Heart, 6 (2), e001108
   DOI 10.1136/openhrt-2019-001108, PubMed 31673391
3. Atar D, Grundvold I (2019)
   On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient?
   Eur Heart J, 40 (19), 1501-1503
   DOI 10.1093/eurheartj/ehz014, PubMed 30753396
4. Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2019)
   Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population
   Atherosclerosis, 286, 53-59
   DOI 10.1016/j.atherosclerosis.2019.05.004, PubMed 31100620
5. Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
   Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
   Blood Press, 29 (2), 123-134
   DOI 10.1080/08037051.2019.1684817, PubMed 31718316
6. Bratseth V, Chiva-Blanch G, Byrkjeland R, Solheim S, Arnesen H, Seljeflot I (2019)
   Elevated levels of circulating microvesicles in coronary artery disease patients with type 2 diabetes and albuminuria: Effects of exercise training
   Diab Vasc Dis Res, 16 (5), 431-439
   DOI 10.1177/1479164119843094, PubMed 31023084
7. Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2019)
   High Adherence to the Nordic Diet Is Associated with Lower Levels of Total and Platelet-Derived Circulating Microvesicles in a Norwegian Population
   Nutrients, 11 (5)
   DOI 10.3390/nu11051114, PubMed 31109111
8. Cwikiel J, Seljeflot I, Fagerland MW, Wachtell K, Arnesen H, Berge E, Flaa A (2019)
   High-sensitive cardiac Troponin T and exercise stress test for evaluation of angiographically significant coronary disease
   Int J Cardiol, 287, 1-6
   DOI 10.1016/j.ijcard.2019.04.019, PubMed 31006595
9. Danielsen SO, Moons P, Sandvik L, Leegaard M, Solheim S, Tønnessen T, Lie I (2019)
   Impact of telephone follow-up and 24/7 hotline on 30-day readmission rates following aortic valve replacement -A randomized controlled trial
   Int J Cardiol, 300, 66-72
   DOI 10.1016/j.ijcard.2019.07.087, PubMed 31387822
10. Ellingsen DG, Chashchin M, Seljeflot I, Berlinger B, Chashchin V, Stockfelt L, Thomassen Y (2019)
    A study of atherothrombotic biomarkers in welders
    Int Arch Occup Environ Health, 92 (7), 1023-1031
    DOI 10.1007/s00420-019-01441-4, PubMed 31114965
11. Eritsland J, Andersen GO (2019)
    MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI (vol 13, e0206723, 2018)
    PLoS One, 14 (3), e0213636
    DOI 10.1371/journal.pone.0213636
12. Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, Lunde IG, Wakimoto H, Smith AM, Toepfer CN, Getz K, Gorham J, Patel P, Ito K, Willcox JA, Arany Z, Li J, Owens AT, Govind R, Nuñez B, Mazaika E, Bayes-Genis A, Walsh R, Finkelman B, Lupon J, Whiffin N, Serrano I, Midwinter W et al. (2019)
    Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy
    Circulation, 140 (1), 31-41
    DOI 10.1161/CIRCULATIONAHA.118.037934, PubMed 30987448
13. Helseth R, Knudsen EC, Eritsland J, Opstad TB, Arnesen H, Andersen GØ, Seljeflot I (2019)
    Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study
    BMC Cardiovasc Disord, 19 (1), 221
    DOI 10.1186/s12872-019-1205-1, PubMed 31615411
14. Helseth R, Shetelig C, Andersen GØ, Langseth MS, Limalanathan S, Opstad TB, Arnesen H, Hoffmann P, Eritsland J, Seljeflot I (2019)
    Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
    Mediators Inflamm, 2019, 7816491
    DOI 10.1155/2019/7816491, PubMed 31772506
15. Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ (2019)
    Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
    J Diabetes Complications, 33 (5), 383-389
    DOI 10.1016/j.jdiacomp.2019.01.006, PubMed 30846232
16. Kalstad AA, Tveit S, Myhre PL, Laake K, Opstad TB, Tveit A, Schmidt EB, Solheim S, Arnesen H, Seljeflot I (2019)
    Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients
    BMC Geriatr, 19 (1), 376
    DOI 10.1186/s12877-019-1383-9, PubMed 31881852
17. Karlsen H, Bergan HA, Halvorsen PS, Sunde K, Qvigstad E, Andersen GØ, Bugge JF, Olasveengen TM (2019)
    Esmolol for cardioprotection during resuscitation with adrenaline in an ischaemic porcine cardiac arrest model
    Intensive Care Med Exp, 7 (1), 65
    DOI 10.1186/s40635-019-0279-5, PubMed 31802327
18. Knudsen EC, Seljeflot I, Aksnes TA, Eritsland J, Arnesen H, Andersen GØ (2019)
    IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
    PLoS One, 14 (4), e0215640
    DOI 10.1371/journal.pone.0215640, PubMed 31002684
19. Kvakkestad KM, Gran JM, Eritsland J, Holst Hansen C, Fossum E, Andersen GØ, Halvorsen S (2019)
    Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study
    Cardiology, 144 (3-4), 79-89
    DOI 10.1159/000503442, PubMed 31689705
20. Lunde NN, Gregersen I, Ueland T, Shetelig C, Holm S, Kong XY, Michelsen AE, Otterdal K, Yndestad A, Broch K, Gullestad L, Nyman TA, Bendz B, Eritsland J, Hoffmann P, Skagen K, Gonçalves I, Nilsson J, Grenegård M, Poreba M, Drag M, Seljeflot I, Sporsheim B, Espevik T, Skjelland M et al. (2019)
    Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
    Atherosclerosis, 296, 74-82
    DOI 10.1016/j.atherosclerosis.2019.12.008, PubMed 31870625
21. Mariampillai JE, Liestøl K, Kjeldsen SE, Prestgaard EE, Engeseth K, Bodegard J, Berge E, Gjesdal K, Erikssen J, Grundvold I, Skretteberg PT (2019)
    Exercise Systolic Blood Pressure at Moderate Workload Is Linearly Associated With Coronary Disease Risk in Healthy Men
    Hypertension, 75 (1), 44-50
    DOI 10.1161/HYPERTENSIONAHA.119.13528, PubMed 31735088
22. Mariampillai JE, Prestgaard EE, Kjeldsen SE, Liestøl K, Engeseth K, Erikssen J, Bodegard J, Berge E, Grundvold I, Skretteberg PT (2019)
    SBP above 180 mmHg at moderate exercise workload increases coronary heart disease risk in healthy men during 28-year follow-up
    J Hypertens, 37 (5), 949-955
    DOI 10.1097/HJH.0000000000001959, PubMed 30325341
23. Mayerhofer CCK, Awoyemi A, Hov JR, Trøseid M, Broch K (2019)
    Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure
    ESC Heart Fail, 6 (3), 557-558
    DOI 10.1002/ehf2.12437, PubMed 31034162
24. Mohammadzadeh N, Lunde IG, Andenæs K, Strand ME, Aronsen JM, Skrbic B, Marstein HS, Bandlien C, Nygård S, Gorham J, Sjaastad I, Chakravarti S, Christensen G, Engebretsen KVT, Tønnessen T (2019)
    The extracellular matrix proteoglycan lumican improves survival and counteracts cardiac dilatation and failure in mice subjected to pressure overload
    Sci Rep, 9 (1), 9206
    DOI 10.1038/s41598-019-45651-9, PubMed 31235849
25. Opstad TB, Kalstad AA, Pettersen AÅ, Arnesen H, Seljeflot I (2019)
    Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease
    Exp Gerontol, 119, 53-60
    DOI 10.1016/j.exger.2019.01.020, PubMed 30684534
26. Røe ÅT, Ruud M, Espe EK, Manfra O, Longobardi S, Aronsen JM, Nordén ES, Husebye T, Kolstad TRS, Cataliotti A, Christensen G, Sejersted OM, Niederer SA, Andersen GØ, Sjaastad I, Louch WE (2019)
    Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
    Cardiovasc Res, 115 (4), 752-764
    DOI 10.1093/cvr/cvy257, PubMed 30351410
27. Schultz NH, Holme PA, Henriksson CE, Mowinckel MC, Sandset PM, Bratseth V, Jacobsen EM (2019)
    The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
    Thromb Res, 177, 154-156
    DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875
28. Solberg OG, Stavem K, Ragnarsson A, Beitnes JO, Skårdal R, Seljeflot I, Ueland T, Aukrust P, Gullestad L, Aaberge L (2019)
    Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study
    Catheter Cardiovasc Interv, 94 (5), 660-668
    DOI 10.1002/ccd.28157, PubMed 30790446
29. Tveit SH, Myhre PL, Hoff NJS, Le TM, Seljeflot I, Røysland R, Høiseth AD, Røsjø H, Omland T (2019)
    Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac Examination (ACE) 3 study
    Clin Biochem, 78, 10-17
    DOI 10.1016/j.clinbiochem.2019.12.016, PubMed 31899280
30. Warlo EMK, Arnesen H, Seljeflot I (2019)
    A brief review on resistance to P2Y₁₂ receptor antagonism in coronary artery disease
    Thromb J, 17, 11
    DOI 10.1186/s12959-019-0197-5, PubMed 31198410
31. Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
    Effects of exercise training on inflammasome-related mediators and their associations to glucometabolic variables in patients with combined coronary artery disease and type 2 diabetes mellitus: Sub-study of a randomized control trial
    Diab Vasc Dis Res, 16 (4), 360-368
    DOI 10.1177/1479164119836922, PubMed 30939905
32. Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
    Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial
    Diabetol Metab Syndr, 11, 109
    DOI 10.1186/s13098-019-0508-9, PubMed 31890043

Publications 2018

1. Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2018)
   Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study
   Diabetol Metab Syndr, 10, 59
   DOI 10.1186/s13098-018-0360-3, PubMed 30038669
2. Bethke A, Shanmuganathan L, Andersen GØ, Eritsland J, Swanson D, Kløw NE, Hoffmann P (2018)
   Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings
   Eur Radiol, 29 (2), 941-950
   DOI 10.1007/s00330-018-5588-7, PubMed 29980929
3. Bethke A, Shanmuganathan L, Shetelig C, Swanson D, Andersen GØ, Eritsland J, Kløw NE, Hoffmann P (2018)
   MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
   PLoS One, 13 (11), e0206723
   DOI 10.1371/journal.pone.0206723, PubMed 30412607
4. Christensen G, Herum KM, Lunde IG (2018)
   Sweet, yet underappreciated: Proteoglycans and extracellular matrix remodeling in heart disease
   Matrix Biol, 75-76, 286-299
   DOI 10.1016/j.matbio.2018.01.001, PubMed 29337052
5. Cwikiel J, Seljeflot I, Berge E, Njerve IU, Ulsaker H, Arnesen H, Flaa A (2018)
   Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease
   Cytokine, 105, 17-22
   DOI 10.1016/j.cyto.2018.02.006, PubMed 29433015
6. Danielsen SO, Moons P, Sandven I, Leegaard M, Solheim S, Tønnessen T, Lie I (2018)
   Thirty-day readmissions in surgical and transcatheter aortic valve replacement: A systematic review and meta-analysis
   Int J Cardiol, 268, 85-91
   DOI 10.1016/j.ijcard.2018.05.026, PubMed 29779575
7. Dhillon AK, Kummen M, Trøseid M, Åkra S, Liaskou E, Moum B, Vesterhus M, Karlsen TH, Seljeflot I, Hov JR (2018)
   Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
   Liver Int, 39 (2), 371-381
   DOI 10.1111/liv.13979, PubMed 30269440
8. Engeseth K, Prestgaard EE, Mariampillai JE, Grundvold I, Liestol K, Kjeldsen SE, Bodegard J, Erikssen JE, Gjesdal K, Skretteberg PT (2018)
   Physical fitness is a modifiable predictor of early cardiovascular death: A 35-year follow-up study of 2014 healthy middle-aged men
   Eur J Prev Cardiol, 25 (15), 1655-1663
   DOI 10.1177/2047487318793459, PubMed 30103630
9. Espeland T, Lunde IG, H Amundsen B, Gullestad L, Aakhus S (2018)
   Myocardial fibrosis
   Tidsskr Nor Laegeforen, 138 (16)
   DOI 10.4045/tidsskr.17.1027, PubMed 30344312
10. Hansen CH, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Seljeflot I (2018)
    Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
    Clin Appl Thromb Hemost, 24 (7), 1088-1094
    DOI 10.1177/1076029618764847, PubMed 29695176
11. Heier M, Espeland CN, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Fugelseth D, Dahl-Jørgensen K (2018)
    Preserved endothelial function in young adults with type 1 diabetes
    PLoS One, 13 (10), e0206523
    DOI 10.1371/journal.pone.0206523, PubMed 30359432
12. Heier M, Stensæth KH, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K (2018)
    Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study
    Eur Heart J Cardiovasc Imaging, 19 (6), 694-700
    DOI 10.1093/ehjci/jex178, PubMed 28950341
13. Hiis HG, Cosson MV, Dahl CP, Fiane AE, Levy FO, Andersen GØ, Krobert KA (2018)
    Hypothermia elongates the contraction-relaxation cycle in explanted human failing heart decreasing the time for ventricular filling during diastole
    Am J Physiol Heart Circ Physiol, 315 (5), H1137-H1147
    DOI 10.1152/ajpheart.00208.2018, PubMed 30004809
14. Hoel H, Hove-Skovsgaard M, Hov JR, Gaardbo JC, Holm K, Kummen M, Rudi K, Nwosu F, Valeur J, Gelpi M, Seljeflot I, Ueland PM, Gerstoft J, Ullum H, Aukrust P, Nielsen SD, Trøseid M (2018)
    Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
    Sci Rep, 8 (1), 6725
    DOI 10.1038/s41598-018-25168-3, PubMed 29712976
15. Horjen AW, Ulimoen SR, Norseth J, Svendsen JH, Smith P, Arnesen H, Seljeflot I, Tveit A (2018)
    High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis
    Scand J Clin Lab Invest, 78 (5), 386-392
    DOI 10.1080/00365513.2018.1481224, PubMed 29933716
16. Kummen M, Mayerhofer CCK, Vestad B, Broch K, Awoyemi A, Storm-Larsen C, Ueland T, Yndestad A, Hov JR, Trøseid M (2018)
    Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts
    J Am Coll Cardiol, 71 (10), 1184-1186
    DOI 10.1016/j.jacc.2017.12.057, PubMed 29519360
17. Langseth MS, Opstad TB, Bratseth V, Solheim S, Arnesen H, Pettersen AÅ, Seljeflot I, Helseth R (2018)
    Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease
    Eur J Prev Cardiol, 25 (7), 762-769
    DOI 10.1177/2047487318760618, PubMed 29473463
18. Mayerhofer CCK, Awoyemi AO, Moscavitch SD, Lappegård KT, Hov JR, Aukrust P, Hovland A, Lorenzo A, Halvorsen S, Seljeflot I, Gullestad L, Trøseid M, Broch K (2018)
    Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
    ESC Heart Fail, 5 (5), 977-984
    DOI 10.1002/ehf2.12332, PubMed 30088346
19. Melleby AO, Romaine A, Aronsen JM, Veras I, Zhang L, Sjaastad I, Lunde IG, Christensen G (2018)
    A novel method for high precision aortic constriction that allows for generation of specific cardiac phenotypes in mice
    Cardiovasc Res, 114 (12), 1680-1690
    DOI 10.1093/cvr/cvy141, PubMed 29878127
20. Munkhaugen J, Hjelmesæth J, Otterstad JE, Helseth R, Sollid ST, Gjertsen E, Gullestad L, Perk J, Moum T, Husebye E, Dammen T (2018)
    Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study
    BMC Cardiovasc Disord, 18 (1), 160
    DOI 10.1186/s12872-018-0896-z, PubMed 30075751
21. Orrem HL, Nilsson PH, Pischke SE, Grindheim G, Garred P, Seljeflot I, Husebye T, Aukrust P, Yndestad A, Andersen GØ, Barratt-Due A, Mollnes TE (2018)
    Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
    ESC Heart Fail, 5 (3), 292-301
    DOI 10.1002/ehf2.12266, PubMed 29424484
22. Orrem HL, Nilsson PH, Pischke SE, Kleveland O, Yndestad A, Ekholt K, Damås JK, Espevik T, Bendz B, Halvorsen B, Gregersen I, Wiseth R, Andersen GØ, Ueland T, Gullestad L, Aukrust P, Barratt-Due A, Mollnes TE (2018)
    IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
    Front Immunol, 9, 2035
    DOI 10.3389/fimmu.2018.02035, PubMed 30258440
23. Orrem HL, Shetelig C, Ueland T, Limalanathan S, Nilsson PH, Husebye T, Aukrust P, Seljeflot I, Hoffmann P, Eritsland J, Mollnes TE, Andersen GØ, Yndestad A (2018)
    Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
    Int J Cardiol, 268, 187-192
    DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279
24. Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen S, Grundvold I, Berge E (2018)
    Change in Cardiorespiratory Fitness and Risk of Stroke and Death: Long-Term Follow-Up of Healthy Middle-Aged Men
    Stroke, 50 (1), 155-161
    DOI 10.1161/STROKEAHA.118.021798, PubMed 30580727
25. Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF (2018)
    Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
    Eur Heart J, 39 (19), 1672-1686f
    DOI 10.1093/eurheartj/ehy066, PubMed 29509886
26. Saetre E, Abdelnoor M (2018)
    Incidence rate of sudden death in epilepsy: A systematic review and meta-analysis
    Epilepsy Behav, 86, 193-199
    DOI 10.1016/j.yebeh.2018.06.037, PubMed 30017838
27. Shetelig C, Limalanathan S, Hoffmann P, Seljeflot I, Gran JM, Eritsland J, Andersen GØ (2018)
    Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
    J Am Coll Cardiol, 72 (2), 187-198
    DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293
28. Staer-Jensen H, Sunde K, Nakstad ER, Eritsland J, Andersen GØ (2018)
    Comparison of three haemodynamic monitoring methods in comatose post cardiac arrest patients
    Scand Cardiovasc J, 52 (3), 141-148
    DOI 10.1080/14017431.2018.1450992, PubMed 29544369
29. Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I (2018)
    Interleukin-18 and the NLR family pyrin domain containing-3 inflammasome in adipose tissue are strongly associated with glucometabolic variables in a cohort of middle-aged men
    Diab Vasc Dis Res, 15 (5), 458-464
    DOI 10.1177/1479164118785307, PubMed 29972041

Publications 2017

1. Abdelnoor M, Andersen JG, Arnesen H, Johansen O (2017)
   Early discharge compared with ordinary discharge after percutaneous coronary intervention - a systematic review and meta-analysis of safety and cost
   Vasc Health Risk Manag, 13, 101-109
   DOI 10.2147/VHRM.S122951, PubMed 28356750
2. Bratseth V, Byrkjeland R, Njerve IU, Solheim S, Arnesen H, Seljeflot I (2017)
   Procoagulant activity in patients with combined type 2 diabetes and coronary artery disease: No effects of long-term exercise training
   Diab Vasc Dis Res, 14 (2), 144-151
   DOI 10.1177/1479164116679080, PubMed 28111966
3. Byrkjeland R, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2017)
   Reduced endothelial activation after exercise is associated with improved HbA_1c in patients with type 2 diabetes and coronary artery disease
   Diab Vasc Dis Res, 14 (2), 94-103
   DOI 10.1177/1479164116679077, PubMed 28111980
4. Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2017)
   Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
   PLoS One, 12 (2), e0172558
   DOI 10.1371/journal.pone.0172558, PubMed 28207887
5. Cwikiel J, Seljeflot I, Berge E, Arnesen H, Wachtell K, Ulsaker H, Flaa A (2017)
   Pro-coagulant activity during exercise testing in patients with coronary artery disease
   Thromb J, 15, 3
   DOI 10.1186/s12959-016-0127-8, PubMed 28115916
6. Ellingsen DG, Seljeflot I, Thomassen Y, Thomassen M, Bakke B, Ulvestad B (2017)
   Biomarkers of endothelial activation and thrombosis in tunnel construction workers exposed to airborne contaminants
   Int Arch Occup Environ Health, 90 (4), 309-317
   DOI 10.1007/s00420-017-1199-x, PubMed 28124139
7. Gharagozlian S, Hansen R, Haugen M, Johansen O, Seierstad SL, Seljeflot I, Arnesen H (2017)
   Changes in dietary pattern when including 700 g of salmon per week to patients with atherosclerotic heart disease
   Clin. Nutr. ESPEN, 19, 38-44
   DOI 10.1016/j.clnesp.2017.02.004
8. Heier M, Borja MS, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K, Oda MN (2017)
   Reduced HDL function in children and young adults with type 1 diabetes
   Cardiovasc Diabetol, 16 (1), 85
   DOI 10.1186/s12933-017-0570-2, PubMed 28683835
9. Herum KM, Lunde IG, McCulloch AD, Christensen G (2017)
   The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart
   J Clin Med, 6 (5)
   DOI 10.3390/jcm6050053, PubMed 28534817
10. Horjen AW, Seljeflot I, Berge T, Smith P, Arnesen H, Tveit A (2017)
    Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation
    Thromb J, 15, 30
    DOI 10.1186/s12959-017-0153-1, PubMed 29299030
11. Hove-Skovsgaard M, Gaardbo JC, Kolte L, Winding K, Seljeflot I, Svardal A, Berge RK, Gerstoft J, Ullum H, Trøseid M, Nielsen SD (2017)
    HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
    BMC Infect Dis, 17 (1), 234
    DOI 10.1186/s12879-017-2334-8, PubMed 28356058
12. Husebye T, Eritsland J, Bjørnerheim R, Andersen GØ (2017)
    Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure
    Eur Heart J Acute Cardiovasc Care, 7 (4), 321-329
    DOI 10.1177/2048872616687114, PubMed 28045338
13. Kvakkestad KM, Sandvik L, Andersen GØ, Sunde K, Halvorsen S (2017)
    Long-term survival in patients with acute myocardial infarction and out-of-hospital cardiac arrest: A prospective cohort study
    Resuscitation, 122, 41-47
    DOI 10.1016/j.resuscitation.2017.11.047, PubMed 29155294
14. Lie I, Danielsen SO, Tønnessen T, Solheim S, Leegaard M, Sandvik L, Wisløff T, Vangen J, Røsstad TH, Moons P (2017)
    Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial
    Trials, 18 (1), 246
    DOI 10.1186/s13063-017-1971-y, PubMed 28693599
15. Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Norseth J, Arnesen H, Solheim S (2017)
    Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study
    JRSM Cardiovasc Dis, 6, 2048004017729984
    DOI 10.1177/2048004017729984, PubMed 28932392
16. Mariampillai JE, Engeseth K, Kjeldsen SE, Grundvold I, Liestøl K, Erikssen G, Erikssen J, Bodegard J, Skretteberg PT (2017)
    Exercise systolic blood pressure at moderate workload predicts cardiovascular disease and mortality through 35 years of follow-up in healthy, middle-aged men
    Blood Press, 26 (4), 229-236
    DOI 10.1080/08037051.2017.1291276, PubMed 28276720
17. Myhre PL, Stridsberg M, Linko R, Okkonen M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H, FINNALI Study Group (2017)
    Circulating chromogranin B levels in patients with acute respiratory failure: data from the FINNALI Study
    Biomarkers, 22 (8), 775-781
    DOI 10.1080/1354750X.2016.1269200, PubMed 28049363
18. Njerve IU, Åkra S, Weiss TW, Solheim S, Øvstebø R, Aass HCD, Byrkjeland R, Arnesen H, Seljeflot I (2017)
    A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
    Mediators Inflamm, 2017, 5380638
    DOI 10.1155/2017/5380638, PubMed 28596642
19. Opstad TB, Seljeflot I, Bøhmer E, Arnesen H, Halvorsen S (2017)
    MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy
    Cardiology, 139 (1), 17-24
    DOI 10.1159/000481684, PubMed 29141241
20. Prestgaard E, Hodnesdal C, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen SE, Grundvold I, Berge E (2017)
    Long-term predictors of stroke in healthy middle-aged men
    Int J Stroke, 13 (3), 292-300
    DOI 10.1177/1747493017730760, PubMed 28929941
21. Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
    Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
    Sci Rep, 7 (1), 11945
    DOI 10.1038/s41598-017-12372-w, PubMed 28931920
22. Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
    Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
    PLoS One, 12 (3), e0173034
    DOI 10.1371/journal.pone.0173034, PubMed 28253327
23. Warlo EMK, Pettersen AR, Arnesen H, Seljeflot I (2017)
    vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
    Thromb J, 15, 28
    DOI 10.1186/s12959-017-0151-3, PubMed 29200971
24. Wexels F, Dahl OE, Pripp AH, Seljeflot I (2017)
    Thrombin Generation in Patients With Suspected Venous Thromboembolism
    Clin Appl Thromb Hemost, 23 (5), 416-421
    DOI 10.1177/1076029617700999, PubMed 28335612

Publications 2016

1. Abdelnoor M, Vengen ØA, Johansen O, Sandven I, Abdelnoor AM (2016)
   Latitude of the study place and age of the patient are associated with incidence of mediastinitis and microbiology in open-heart surgery: a systematic review and meta-analysis
   Clin Epidemiol, 8, 151-63
   DOI 10.2147/CLEP.S96107, PubMed 27330329
2. Beitland S, Nakstad ER, Staer-Jensen H, Draegni T, Andersen GØ, Jacobsen D, Brunborg C, Waldum-Grevbo B, Sunde K (2016)
   Impact of acute kidney injury on patient outcome in out-of-hospital cardiac arrest: a prospective observational study
   Acta Anaesthesiol Scand, 60 (8), 1170-81
   DOI 10.1111/aas.12753, PubMed 27306254
3. Beitland S, Waldum-Grevbo BE, Nakstad ER, Berg JP, Trøseid AS, Brusletto BS, Brunborg C, Andersen GØ, Sunde K (2016)
   Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest
   Crit Care, 20 (1), 314
   DOI 10.1186/s13054-016-1503-2, PubMed 27716377
4. Bliksøen M, Mariero LH, Torp MK, Baysa A, Ytrehus K, Haugen F, Seljeflot I, Vaage J, Valen G, Stensløkken KO (2016)
   Extracellular mtDNA activates NF-κB via toll-like receptor 9 and induces cell death in cardiomyocytes
   Basic Res Cardiol, 111 (4), 42
   DOI 10.1007/s00395-016-0553-6, PubMed 27164906
5. Byrkjeland R, Stensæth KH, Anderssen S, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2016)
   Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques
   Cardiovasc Diabetol, 15, 13
   DOI 10.1186/s12933-016-0336-2, PubMed 26801098
6. Chiva-Blanch G, Bratseth V, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Badimon L, Seljeflot I (2016)
   Monocyte-derived circulating microparticles (CD14⁺, CD14⁺/CD11b⁺ and CD14⁺/CD142⁺) are related to long-term prognosis for cardiovascular mortality in STEMI patients
   Int J Cardiol, 227, 876-881
   DOI 10.1016/j.ijcard.2016.11.302, PubMed 27915085
7. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Collet JP, Halvorsen S, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Ricci F, Sibbing D, Siegbahn A, Storey RF, Ten Berg J, Verheugt FW, Weitz JI (2016)
   Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
   Thromb Haemost, 115 (4), 685-711
   DOI 10.1160/TH15-09-0703, PubMed 26952877
8. Engeseth K, Hodnesdal C, Grundvold I, Liestøl K, Gjesdal K, Kjeldsen SE, Erikssen JE, Bodegard J, Skretteberg PT (2016)
   Temporal Reduction in Chronotropic Index Predicts Risk of Cardiovascular Death Among Healthy Middle-Aged Men: a 28-Year Follow-Up Study
   J Am Heart Assoc, 5 (12)
   DOI 10.1161/JAHA.116.004555, PubMed 27881424
9. Haissman JM, Haugaard AK, Knudsen A, Kristoffersen US, Seljeflot I, Pedersen KK, Lebech AM, Hasbak P, Kjær A, Ostrowski SR, Gerstoft J, Trøseid M, Nielsen SD (2016)
   Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical Atherosclerosis
   J Acquir Immune Defic Syndr, 73 (5), 507-513
   DOI 10.1097/QAI.0000000000001148, PubMed 27509250
10. Helseth R (2016)
    [Not Available]
    Tidsskr Nor Laegeforen, 136 (10), 945
    DOI 10.4045/tidsskr.16.0318, PubMed 27272379
11. Helseth R, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2016)
    The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris
    Mediators Inflamm, 2016, 2182358
    DOI 10.1155/2016/2182358, PubMed 28074081
12. Horjen AW, Ulimoen SR, Enger S, Norseth J, Seljeflot I, Arnesen H, Tveit A (2016)
    Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing
    BMC Cardiovasc Disord, 16, 79
    DOI 10.1186/s12872-016-0255-x, PubMed 27142292
13. Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Arnesen H, Solheim S (2016)
    Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
    J Lipids, 2016, 4945720
    DOI 10.1155/2016/4945720, PubMed 26989512
14. Myhre PL, Laake K, Seljeflot I, Solheim S, Arnesen H (2016)
    [Clinical research on elderly]
    Tidsskr Nor Laegeforen, 136 (3), 208
    DOI 10.4045/tidsskr.15.1300, PubMed 26860377
15. Myhre PL, Ottesen AH, Okkonen M, Linko R, Stridsberg M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H, FINNALI Laboratory Study Group (2016)
    Prognostic Value of Secretoneurin in Patients with Acute Respiratory Failure: Data from the FINNALI Study
    Clin Chem, 62 (10), 1380-9
    DOI 10.1373/clinchem.2016.258764, PubMed 27540029
16. Myhre PL, Tiainen M, Pettilä V, Vaahersalo J, Hagve TA, Kurola J, Varpula T, Omland T, Røsjø H, FINNRESUSCI Laboratory Study Group (2016)
    NT-proBNP in patients with out-of-hospital cardiac arrest: Results from the FINNRESUSCI Study
    Resuscitation, 104, 12-8
    DOI 10.1016/j.resuscitation.2016.04.007, PubMed 27109503
17. Neerland BE, Hall RJ, Seljeflot I, Frihagen F, MacLullich AM, Raeder J, Wyller TB, Watne LO (2016)
    Associations Between Delirium and Preoperative Cerebrospinal Fluid C-Reactive Protein, Interleukin-6, and Interleukin-6 Receptor in Individuals with Acute Hip Fracture
    J Am Geriatr Soc, 64 (7), 1456-63
    DOI 10.1111/jgs.14238, PubMed 27341529
18. Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I (2016)
    Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
    Diabetes Metab Syndr Obes, 9, 55-62
    DOI 10.2147/DMSO.S96299, PubMed 27042130
19. Næss PA, Engeseth K, Grøtta O, Andersen GØ, Gaarder C (2016)
    Minimal invasive treatment of life-threatening bleeding caused by cardiopulmonary resuscitation-associated liver injury: a case report
    J Med Case Rep, 10 (1), 132
    DOI 10.1186/s13256-016-0926-3, PubMed 27236329
20. Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
    Combined Elevated Levels of the Proinflammatory Cytokines IL-18 and IL-12 Are Associated with Clinical Events in Patients with Coronary Artery Disease: An Observational Study
    Metab Syndr Relat Disord, 14 (5), 242-8
    DOI 10.1089/met.2015.0130, PubMed 27058587
21. Opstad TB, Brusletto BS, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
    Cigarette smoking represses expression of cytokine IL-12 and its regulator miR-21-An observational study in patients with coronary artery disease
    Immunobiology, 222 (2), 169-175
    DOI 10.1016/j.imbio.2016.10.007, PubMed 27765464
22. Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Eritsland J, Fagerland MW, Andersen GØ (2016)
    Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
    J Am Heart Assoc, 5 (6)
    DOI 10.1161/JAHA.115.003014, PubMed 27412895
23. Santos-Gallego CG, Vahl TP, Goliasch G, Picatoste B, Arias T, Ishikawa K, Njerve IU, Sanz J, Narula J, Sengupta PP, Hajjar RJ, Fuster V, Badimon JJ (2016)
    Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion
    Circulation, 133 (10), 954-66
    DOI 10.1161/CIRCULATIONAHA.115.012427, PubMed 26826180
24. Tegn N, Abdelnoor M, Aaberge L, Endresen K, Bendz B (2016)
    Invasive strategy in acute coronary syndrome - Authors' reply
    Lancet, 387 (10037), 2504
    DOI 10.1016/S0140-6736(16)30673-0, PubMed 27353680
25. Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S, Gjertsen E, Dahl-Hofseth O, Ranhoff AH, Gullestad L, Bendz B, After Eighty study investigators (2016)
    Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial
    Lancet, 387 (10023), 1057-1065
    DOI 10.1016/S0140-6736(15)01166-6, PubMed 26794722
26. Wexels F, Seljeflot I, Pripp AH, Dahl OE (2016)
    D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism
    Blood Coagul Fibrinolysis, 27 (4), 396-400
    DOI 10.1097/MBC.0000000000000461, PubMed 26595215

Publications 2015

1. Andric T, Weiss TW, Huber K, Arnesen H, Seljeflot I (2015)
   Effects of diet and/or n-3 fatty acid supplementation on components of the interleukin-6 trans-signalling system in elderly men
   Scand J Clin Lab Invest, 75 (8), 646-51
   DOI 10.3109/00365513.2015.1063002, PubMed 26179891
2. Berg IJ, van der Heijde D, Dagfinrud H, Seljeflot I, Olsen IC, Kvien TK, Semb AG, Provan SA (2015)
   Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study
   J Rheumatol, 42 (4), 645-53
   DOI 10.3899/jrheum.141018, PubMed 25641897
3. Bethke A, Halvorsen S, Bøhmer E, Abdelnoor M, Arnesen H, Hoffmann P (2015)
   Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty)
   EuroIntervention, 11 (5), 518-24
   DOI 10.4244/EIJY15M04_02, PubMed 25868877
4. Byrkjeland R, Njerve IU, Anderssen S, Arnesen H, Seljeflot I, Solheim S (2015)
   Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: A randomised clinical trial
   Diab Vasc Dis Res, 12 (5), 325-33
   DOI 10.1177/1479164115590552, PubMed 26092822
5. Cero FT, Hillestad V, Sjaastad I, Yndestad A, Aukrust P, Ranheim T, Lunde IG, Olsen MB, Lien E, Zhang L, Haugstad SB, Løberg EM, Christensen G, Larsen KO, Skjønsberg OH (2015)
   Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice
   Am J Physiol Lung Cell Mol Physiol, 309 (4), L378-87
   DOI 10.1152/ajplung.00342.2014, PubMed 26071556
6. Dudek D, Siudak Z, Solheim S (2015)
   New model of secondary cardiovascular prevention for patients after acute coronary syndromes in Poland with regard to Norwegian experiences
   Kardiol Pol, 74 (2), 101-3
   DOI 10.5603/KP.a2015.0176, PubMed 26365935
7. Ellingsen DG, Ulvestad B, Bakke B, Seljeflot I, Barregard L, Thomassen Y (2015)
   Serum pneumoproteins in tunnel construction workers
   Int Arch Occup Environ Health, 88 (7), 943-51
   DOI 10.1007/s00420-015-1023-4, PubMed 25632885
8. Gjesdal K, Grundvold I (2015)
   Atrial fibrillation and exercise in women: some answers given, some questions remain
   Heart, 101 (20), 1605-6
   DOI 10.1136/heartjnl-2015-307836, PubMed 26206848
9. Grundvold I, Bodegard J, Nilsson PM, Svennblad B, Johansson G, Östgren CJ, Sundström J (2015)
   Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study
   Cardiovasc Diabetol, 14, 5
   DOI 10.1186/s12933-014-0170-3, PubMed 25589001
10. Halvorsen B, Espeland MZ, Andersen GØ, Yndestad A, Sagen EL, Rashidi A, Knudsen EC, Skjelland M, Skagen KR, Krohg-Sørensen K, Holm S, Ritschel V, Holven KB, Biessen EA, Aukrust P, Dahl TB (2015)
    Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages
    Atherosclerosis, 243 (1), 204-10
    DOI 10.1016/j.atherosclerosis.2015.09.010, PubMed 26402139
11. Hansen CH, Ritschel V, Halvorsen S, Andersen GØ, Bjørnerheim R, Eritsland J, Arnesen H, Seljeflot I (2015)
    Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
    Thromb J, 13, 31
    DOI 10.1186/s12959-015-0061-1, PubMed 26396552
12. Heier M, Margeirsdottir HD, Gaarder M, Stensæth KH, Brunborg C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jørgensen K (2015)
    Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
    Cardiovasc Diabetol, 14, 126
    DOI 10.1186/s12933-015-0292-2, PubMed 26408307
13. Heier M, Margeirsdottir HD, Torjesen PA, Seljeflot I, Stensæth KH, Gaarder M, Brunborg C, Hanssen KF, Dahl-Jørgensen K (2015)
    The advanced glycation end product methylglyoxal-derived hydroimidazolone-1 and early signs of atherosclerosis in childhood diabetes
    Diab Vasc Dis Res, 12 (2), 139-45
    DOI 10.1177/1479164114560910, PubMed 25616705
14. Helseth R, Opstad T, Solheim S, Lunde K, Arnesen H, Seljeflot I (2015)
    The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction
    Cardiol Res, 6 (1), 209-215
    DOI 10.14740/cr375w, PubMed 28197227
15. Helseth R, Weiss TW, Opstad TB, Siegbahn A, Solheim S, Freynhofer MK, Huber K, Arnesen H, Seljeflot S (2015)
    Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction
    Thromb Res, 136 (6), 1240-4
    DOI 10.1016/j.thromres.2015.10.005, PubMed 26475405
16. Horjen AW, Ulimoen SR, Seljeflot I, Smith P, Arnesen H, Norseth J, Tveit A (2015)
    High-Sensitivity Troponin I and Rhythm Outcome after Electrical Cardioversion for Persistent Atrial Fibrillation
    Cardiology, 133 (4), 233-8
    DOI 10.1159/000442249, PubMed 26697854
17. Lindholm EE, Aune E, Seljeflot I, Otterstad JE, Kirkebøen KA (2015)
    Biomarkers of inflammation in major vascular surgery: a prospective randomised trial
    Acta Anaesthesiol Scand, 59 (6), 773-87
    DOI 10.1111/aas.12466, PubMed 25626738
18. Laake K, Seljeflot I, Fagerland MW, Njerve IU, Arnesen H, Solheim S (2015)
    Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome
    Mediators Inflamm, 2015, 373070
    DOI 10.1155/2015/373070, PubMed 25733777
19. Pettersen AA, Arnesen H, Seljeflot I (2015)
    A brief review on high on-aspirin residual platelet reactivity
    Vascul Pharmacol, 67-69, 6-9
    DOI 10.1016/j.vph.2015.03.018, PubMed 25869498
20. Skrede K, Wyller TB, Watne LO, Seljeflot I, Juliebø V (2015)
    Is there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients
    BMC Res Notes, 8, 186
    DOI 10.1186/s13104-015-1129-5, PubMed 25943983
21. Stær-Jensen H, Nakstad ER, Fossum E, Mangschau A, Eritsland J, Drægni T, Jacobsen D, Sunde K, Andersen GØ (2015)
    Post-Resuscitation ECG for Selection of Patients for Immediate Coronary Angiography in Out-of-Hospital Cardiac Arrest
    Circ Cardiovasc Interv, 8 (10)
    DOI 10.1161/CIRCINTERVENTIONS.115.002784, PubMed 26453688
22. Stær-Jensen H, Sunde K, Andersen GØ (2015)
    The authors reply
    Crit Care Med, 43 (3), e98
    DOI 10.1097/CCM.0000000000000812, PubMed 25700077
23. Sunde K, Andersen GØ (2015)
    Prediction of outcome after out-of-hospital cardiac arrest already on hospital admission-not reliable enough to be true!
    Eur Heart J, 37 (42), 3229-3231
    DOI 10.1093/eurheartj/ehv490, PubMed 26516178
24. Trøseid M, Nestvold TK, Nielsen EW, Thoresen H, Seljeflot I, Lappegård KT (2015)
    Soluble CD14 is associated with markers of vascular dysfunction in bariatric surgery patients
    Metab Syndr Relat Disord, 13 (3), 119-24
    DOI 10.1089/met.2014.0111, PubMed 25562385
25. Ørstavik Ø, Manfra O, Andressen KW, Andersen GØ, Skomedal T, Osnes JB, Levy FO, Krobert KA (2015)
    The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium
    PLoS One, 10 (3), e0115547
    DOI 10.1371/journal.pone.0115547, PubMed 25738589

Publications 2014

1. Abdelnoor M, Sandven I, Limalanathan S, Eritsland J (2014)
   Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials
   Vasc Health Risk Manag, 10, 477-91
   DOI 10.2147/VHRM.S67154, PubMed 25143742
2. Andersen GØ (2014)
   Circulatory shock
   N Engl J Med, 370 (6), 583
   DOI 10.1056/NEJMc1314999, PubMed 24499234
3. Byrkjeland R, Edvardsen E, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2014)
   Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease
   Diabetol Metab Syndr, 6 (1), 36
   DOI 10.1186/1758-5996-6-36, PubMed 24612649
4. Bøhmer E, Kristiansen IS, Arnesen H, Halvorsen S (2014)
   Health-related quality of life after myocardial infarction, does choice of method make a difference?
   Scand Cardiovasc J, 48 (4), 216-22
   DOI 10.3109/14017431.2014.923581, PubMed 24828790
5. Engeseth K, Hodnesdal C, Grundvold I, Liestøl K, Gjesdal K, Erikssen G, Kjeldsen SE, Erikssen JE, Bodegard J, Skretteberg PT (2014)
   Heart rate reserve predicts cardiovascular death among physically unfit but otherwise healthy middle-aged men: a 35-year follow-up study
   Eur J Prev Cardiol, 23 (1), 59-66
   DOI 10.1177/2047487314553202, PubMed 25281482
6. Furenes EB, Opstad TB, Solheim S, Lunde K, Arnesen H, Seljeflot I (2014)
   The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction
   Mediators Inflamm, 2014, 385901
   DOI 10.1155/2014/385901, PubMed 25294955
7. Heier M, Margeirsdottir HD, Brunborg C, Hanssen KF, Dahl-Jørgensen K, Seljeflot I (2014)
   Inflammation in childhood type 1 diabetes; influence of glycemic control
   Atherosclerosis, 238 (1), 33-7
   DOI 10.1016/j.atherosclerosis.2014.11.018, PubMed 25437887
8. Helseth R, Seljeflot I, Opstad T, Solheim S, Freynhofer M, Arnesen H, Huber K, Weiss T (2014)
   Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction
   Thromb Res, 135 (2), 329-33
   DOI 10.1016/j.thromres.2014.11.028, PubMed 25496999
9. Helseth R, Solheim S, Opstad T, Hoffmann P, Arnesen H, Seljeflot I (2014)
   The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention
   Mediators Inflamm, 2014, 608414
   DOI 10.1155/2014/608414, PubMed 24737925
10. Husebye T, Eritsland J, Arnesen H, Bjørnerheim R, Mangschau A, Seljeflot I, Andersen GØ (2014)
    Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure
    PLoS One, 9 (11), e112359
    DOI 10.1371/journal.pone.0112359, PubMed 25390695
11. Husted S, de Caterina R, Andreotti F, Arnesen H, Bachmann F, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Storey RF, Weitz JI, ESC Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease (2014)
    Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel
    Thromb Haemost, 111 (5), 781-2
    DOI 10.1160/TH14-03-0228, PubMed 24658395
12. Limalanathan S, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P, Eritsland J (2014)
    Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial
    J Am Heart Assoc, 3 (2), e000679
    DOI 10.1161/JAHA.113.000679, PubMed 24760962
13. Laake K, Myhre P, Nordby LM, Seljeflot I, Abdelnoor M, Smith P, Tveit A, Arnesen H, Solheim S (2014)
    Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study
    BMC Geriatr, 14, 74
    DOI 10.1186/1471-2318-14-74, PubMed 24928284
14. Njerve IU, Solheim S, Lunde K, Hoffmann P, Arnesen H, Seljeflot I (2014)
    Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
    Cytokine, 69 (1), 131-5
    DOI 10.1016/j.cyto.2014.05.022, PubMed 24930044
15. Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2014)
    The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease
    PLoS One, 9 (9), e106816
    DOI 10.1371/journal.pone.0106816, PubMed 25191702
16. Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GØ, Levy FO, Skomedal T, Osnes JB, Qvigstad E (2014)
    Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart
    Br J Pharmacol, 171 (23), 5169-81
    DOI 10.1111/bph.12647, PubMed 24547784
17. Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
    Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
    J Acquir Immune Defic Syndr, 67 (4), 370-4
    DOI 10.1097/QAI.0000000000000339, PubMed 25226210
18. Stær-Jensen H, Sunde K, Olasveengen TM, Jacobsen D, Drægni T, Nakstad ER, Eritsland J, Andersen GØ (2014)
    Bradycardia during therapeutic hypothermia is associated with good neurologic outcome in comatose survivors of out-of-hospital cardiac arrest
    Crit Care Med, 42 (11), 2401-8
    DOI 10.1097/CCM.0000000000000515, PubMed 25072762
19. Sveen KA, Dahl-Jørgensen K, Stensaeth KH, Angel K, Seljeflot I, Sell DR, Monnier VM, Hanssen KF (2014)
    Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes
    J Diabetes Complications, 29 (3), 407-12
    DOI 10.1016/j.jdiacomp.2014.12.011, PubMed 25600701
20. Svendsen M, Tonstad S, Heggen E, Pedersen TR, Seljeflot I, Bøhn SK, Bastani NE, Blomhoff R, Holme IM, Klemsdal TO (2014)
    The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: a randomized, controlled study
    Blood Press, 24 (1), 48-54
    DOI 10.3109/08037051.2014.976979, PubMed 25483553
21. Ulimoen SR, Enger S, Norseth J, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A (2014)
    Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation
    Clin Cardiol, 37 (7), 422-7
    DOI 10.1002/clc.22281, PubMed 24700386
22. Wexels F, Dahl OE, Pripp AH, Seljeflot I, Borris LC, Haslund A, Gudmundsen TE, Lauritzen T, Lassen MR (2014)
    Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism
    Thromb Res, 134 (1), 68-71
    DOI 10.1016/j.thromres.2014.04.011, PubMed 24824294
23. Wonnerth A, Katsaros KM, Krychtiuk KA, Speidl WS, Kaun C, Thaler K, Huber K, Wojta J, Maurer G, Seljeflot I, Arnesen H, Weiss TW (2014)
    Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels
    Metabolism, 63 (5), 647-53
    DOI 10.1016/j.metabol.2014.02.005, PubMed 24629561

Publications 2013

1. Arnesen H, Seljeflot I (2013)
   The challenge of judging data on the effects of N-3 fatty acids in CHD
   Scand Cardiovasc J, 47 (2), 67-8
   DOI 10.3109/14017431.2012.761348, PubMed 23327650
2. Berge T, Ulimoen SR, Enger S, Arnesen H, Seljeflot I, Tveit A (2013)
   Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly
   Scand J Clin Lab Invest, 73 (4), 326-33
   DOI 10.3109/00365513.2013.780093, PubMed 23586783
3. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI (2013)
   Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease
   Thromb Haemost, 110 (6), 1087-107
   DOI 10.1160/TH13-06-0443, PubMed 24226379
4. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI, European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease (2013)
   General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease
   Thromb Haemost, 109 (4), 569-79
   DOI 10.1160/TH12-10-0772, PubMed 23447024
5. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI, European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease (2013)
   Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease
   Thromb Haemost, 109 (5), 769-86
   DOI 10.1160/TH12-06-0403, PubMed 23636477
6. Grundvold I, Skretteberg PT, Engeseth K, Gjesdal K, Kjeldsen SE, Arnesen H, Bodegard J, Liestøl K, Erikssen G, Erikssen J (2013)
   Response to Letter by Morris et al regarding article, "Low heart rates predict incident atrial fibrillation in healthy middle-aged men" by Grundvold et al
   Circ Arrhythm Electrophysiol, 6 (6), e102
   DOI 10.1161/CIRCEP.113.001154, PubMed 24347602
7. Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Engeseth K, Gjesdal K, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2013)
   Low heart rates predict incident atrial fibrillation in healthy middle-aged men
   Circ Arrhythm Electrophysiol, 6 (4), 726-31
   DOI 10.1161/CIRCEP.113.000267, PubMed 23873309
8. Hopp E, Bjørnerud A, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ (2013)
   Perfusion MRI at rest in subacute and chronic myocardial infarct
   Acta Radiol, 54 (4), 401-11
   DOI 10.1177/0284185113475605, PubMed 23401603
9. Husebye T, Eritsland J, Müller C, Sandvik L, Arnesen H, Seljeflot I, Mangschau A, Bjørnerheim R, Andersen GØ (2013)
   Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study
   Eur J Heart Fail, 15 (5), 565-72
   DOI 10.1093/eurjhf/hfs215, PubMed 23288914
10. Limalanathan S, Eritsland J, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P (2013)
    Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMR
    PLoS One, 8 (8), e71780
    DOI 10.1371/journal.pone.0071780, PubMed 23977143
11. Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2013)
    The co-existence of the IL-18+183 A/G and MMP-9 -1562 C/T polymorphisms is associated with clinical events in coronary artery disease patients
    PLoS One, 8 (9), e74498
    DOI 10.1371/journal.pone.0074498, PubMed 24040261
12. Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J, Andersen GØ (2013)
    IL-6 signalling in patients with acute ST-elevation myocardial infarction
    Results Immunol, 4, 8-13
    DOI 10.1016/j.rinim.2013.11.002, PubMed 24707455
13. Rohla M, Freynhofer MK, Hammerl H, Weiss TW, Huber K (2013)
    Stroke and recurrent left atrial appendage thrombus in a patient with atrial fibrillation under old and new oral anticoagulants: a case report
    Thromb Haemost, 111 (2), 375-8
    DOI 10.1160/TH13-06-0446, PubMed 24136295
14. Rohla M, Freynhofer MK, Tentzeris I, Farhan S, Wojta J, Huber K, Weiss TW (2013)
    Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Eur Heart J Acute Cardiovasc Care, 3 (1), 84-92
    DOI 10.1177/2048872613516018, PubMed 24337920
15. Rønning B, Wyller TB, Jordhøy MS, Nesbakken A, Bakka A, Seljeflot I, Kristjansson SR (2013)
    Frailty indicators and functional status in older patients after colorectal cancer surgery
    J Geriatr Oncol, 5 (1), 26-32
    DOI 10.1016/j.jgo.2013.08.001, PubMed 24484715
16. Skretteberg PT, Grundvold I, Kjeldsen SE, Engeseth K, Liestøl K, Erikssen G, Erikssen J, Gjesdal K, Bodegard J (2013)
    Seven-year increase in exercise systolic blood pressure at moderate workload predicts long-term risk of coronary heart disease and mortality in healthy middle-aged men
    Hypertension, 61 (5), 1134-40
    DOI 10.1161/HYPERTENSIONAHA.111.00793, PubMed 23529164
17. Skretteberg PT, Grytten AN, Gjertsen K, Grundvold I, Kjeldsen SE, Erikssen J, Mellbin L, Liestøl K, Fraser DA, Erikssen G, Pedersen TR, Bodegard J (2013)
    Triglycerides-diabetes association in healthy middle-aged men: modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia Study
    Diabetes Res Clin Pract, 101 (2), 201-9
    DOI 10.1016/j.diabres.2013.06.001, PubMed 23827210
18. Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2013)
    Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
    Thromb J, 11 (1), 1
    DOI 10.1186/1477-9560-11-1, PubMed 23311309
19. Tveit A, Seljeflot I, Smith P, Arnesen H, Svendsen JH (2013)
    Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation
    Immunobiology, 218 (10), 1256-60
    DOI 10.1016/j.imbio.2013.04.014, PubMed 23731775
20. Ulimoen SR, Enger S, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A (2013)
    Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation
    Eur Heart J, 35 (8), 517-24
    DOI 10.1093/eurheartj/eht429, PubMed 24135831
21. Vengen OA, Abdelnoor M, Westheim AS, Smith G, Fjeld NB (2013)
    Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier
    J Cardiothorac Surg, 8, 142
    DOI 10.1186/1749-8090-8-142, PubMed 23724788
22. Weiss TW, Arnesen H, Seljeflot I (2013)
    Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness
    Metabolism, 62 (7), 1008-13
    DOI 10.1016/j.metabol.2013.01.019, PubMed 23428306
23. Wexels F, Haslund A, Dahl OE, Pripp AH, Gudmundsen TE, Laszlo F, Seljeflot I, Borris LC, Lassen MR (2013)
    Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification
    Thromb Res, 131 (6), 560-3
    DOI 10.1016/j.thromres.2013.04.019, PubMed 23680105

Publications 2012

1. Abdelnoor M, Eritsland J, Brunborg C, Halvorsen S (2012)
   Ethnicity and acute myocardial infarction: risk profile at presentation, access to hospital management, and outcome in Norway
   Vasc Health Risk Manag, 8, 505-15
   DOI 10.2147/VHRM.S33627, PubMed 22956878
2. Angel K, Provan SA, Mowinckel P, Seljeflot I, Kvien TK, Atar D (2012)
   The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness
   Atherosclerosis, 225 (1), 160-5
   DOI 10.1016/j.atherosclerosis.2012.08.033, PubMed 23014354
3. Bliksøen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GØ, Aukrust P, Valen G, Vinge LE (2012)
   Increased circulating mitochondrial DNA after myocardial infarction
   Int J Cardiol, 158 (1), 132-4
   DOI 10.1016/j.ijcard.2012.04.047, PubMed 22578950
4. Bratseth V, Pettersen AÅ, Opstad TB, Arnesen H, Seljeflot I (2012)
   Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
   Thromb J, 10 (1), 12
   DOI 10.1186/1477-9560-10-12, PubMed 22883224
5. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI, Coordinating Committee (2012)
   New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper
   J Am Coll Cardiol, 59 (16), 1413-25
   DOI 10.1016/j.jacc.2012.02.008, PubMed 22497820
6. Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
   The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial
   Diabetes Care, 35 (5), 1095-7
   DOI 10.2337/dc11-1895, PubMed 22446172
7. Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
   Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095-1097
   Diabetes Care, 35 (11), E80
   DOI 10.2337/dc12-1124
8. Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2012)
   Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study
   Hypertension, 59 (2), 198-204
   DOI 10.1161/HYPERTENSIONAHA.111.179713, PubMed 22252392
9. Grundvold I, Skretteberg PT, Liestøl K, Gjesdal K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2012)
   Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men
   Am J Cardiol, 110 (3), 425-32
   DOI 10.1016/j.amjcard.2012.03.043, PubMed 22579085
10. Halvorsen S (2012)
    STEMI treatment in areas remote from primary PCI centres
    EuroIntervention, 8 Suppl P, P44-50
    DOI 10.4244/EIJV8SPA8, PubMed 22917789
11. Halvorsen S, Seljeflot I, Weiss T, Bøhmer E, Arnesen H (2012)
    Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy
    Thromb Res, 130 (3), 495-500
    DOI 10.1016/j.thromres.2012.04.016, PubMed 22607887
12. Hassellund SS, Flaa A, Kjeldsen SE, Seljeflot I, Karlsen A, Erlund I, Rostrup M (2012)
    Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study
    J Hum Hypertens, 27 (2), 100-6
    DOI 10.1038/jhh.2012.4, PubMed 22336903
13. Karlsen A, Svendsen M, Seljeflot I, Laake P, Duttaroy AK, Drevon CA, Arnesen H, Tonstad S, Blomhoff R (2012)
    Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers
    J Hum Hypertens, 27 (2), 126-30
    DOI 10.1038/jhh.2011.116, PubMed 22258209
14. Lie I, Bunch EH, Smeby NA, Arnesen H, Hamilton G (2012)
    Patients' experiences with symptoms and needs in the early rehabilitation phase after coronary artery bypass grafting
    Eur J Cardiovasc Nurs, 11 (1), 14-24
    DOI 10.1016/j.ejcnurse.2010.09.004, PubMed 21030311
15. Lindholm E, Seljeflot I, Aune E, Kirkebøen KA (2012)
    Proinflammatory cytokines and complement activation in salvaged blood from abdominal aortic aneurism surgery and total hip replacement surgery
    Transfusion, 52 (8), 1761-9
    DOI 10.1111/j.1537-2995.2011.03528.x, PubMed 22304534
16. Njerve IU, Pettersen AÅ, Opstad TB, Arnesen H, Seljeflot I (2012)
    Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus
    Metab Syndr Relat Disord, 10 (6), 400-6
    DOI 10.1089/met.2012.0052, PubMed 22897138
17. Pettersen AÅ, Arnesen H, Opstad TB, Bratseth V, Seljeflot I (2012)
    Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease
    Thromb Res, 130 (3), 424-8
    DOI 10.1016/j.thromres.2012.06.016, PubMed 22795340
18. Pettersen AÅ, Seljeflot I, Abdelnoor M, Arnesen H (2012)
    High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)
    J Am Heart Assoc, 1 (3), e000703
    DOI 10.1161/JAHA.112.000703, PubMed 23130135
19. Prendergast B, Coope LT, Crijns H, Falkenstein E, Fölsch U, Halvorsen S, Janssens S, Jokinen E, Kroemer HK, Lücke A, Murer H, Nagel E, Neyses L, Perk J, Probst-Hensch N, Rietschel ET, Rütten H, Steingen C, Tedgui A, van Gilst W, Eschenhagen T, Kristensen SD (2012)
    The German Centre for Cardiovascular Research
    Eur Heart J, 33 (9), 1033-36,1036a
    PubMed 22893891
20. Seljeflot I (2012)
    Plasma asymmetric dimethylarginine in patients with acute decompensation of chronic heart failure
    Heart, 98 (11), 831-2
    DOI 10.1136/heartjnl-2012-301932, PubMed 22581731
21. Seljeflot I, R Ulimoen S, Enger S, Bratseth V, Arnesen H, Tveit A (2012)
    Asymmetric Dimethylarginine Levels are Highly Associated With Atrial Fibrillation in an Elderly Population
    Cardiol Res, 3 (3), 109-115
    DOI 10.4021/cr175w, PubMed 28352406
22. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D (2012)
    ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    Eur Heart J, 33 (20), 2569-619
    DOI 10.1093/eurheartj/ehs215, PubMed 22922416
23. Ulimoen SR, Enger S, Carlson J, Platonov PG, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A (2012)
    Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation
    Am J Cardiol, 111 (2), 225-30
    DOI 10.1016/j.amjcard.2012.09.020, PubMed 23111138
24. Wisløff T, Selmer RM, Halvorsen S, Fretheim A, Norheim OF, Kristiansen IS (2012)
    Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease--a cost-effectiveness analysis
    BMC Cardiovasc Disord, 12, 26
    DOI 10.1186/1471-2261-12-26, PubMed 22475076